Capstone Therapeutics extends maturity of July 2025 senior secured convertible note to Aug. 29, 2026

• Capstone Therapeutics amended a senior secured convertible note, extending the maturity of its July 2025 note to Aug. 29, 2026.
• The note was originally issued on July 29, 2025 with an original principal amount of about $3.27 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-025475), on August 03, 2026, and is solely responsible for the information contained therein.